Analysis reportAll specifications met
Retatrutide 30mg
Peptide Stock ref. PSV-2610-RT30-01
Purity99.92%HPLC, area %
Content per vial37.88 mg126.3% of 30 mg label claim
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Chromatographic purity (HPLC, area %) | — | 99.92% | Reported |
| Content per vial | ≥ 90% of 30 mg label claim | 37.88 mg (126.3% of claim) | Pass |
About this report
- Sample received by the lab 5 October 2026; report issued —.
- Results relate to the sample tested. For laboratory research use only.